Aprotinin in high-risk isolated coronary artery bypass graft patients: a 3-year propensity matched study
Aprotinin, a serine protease inhibitor, has been used variably in cardiac surgery amidst ongoing debates about its safety following several previous studies. This study assesses the outcomes of aprotinin in hi… Read More